Professor Michael Keane MB BCh BAO MRCPI MD

Research Interests:

GRANT SUPPORT
Current

SFI PI Award, Principal Investigator, IL-13 receptor in lung injury and remodelling. €1,206,361 direct costs

NIH RO1 HL080206, Co-Investigator, The role of chemokines during lung allograft rejection. 8/1/05-7/31/09. $1,250,000 direct costs

Recent

 NIH RO1 AR055075, Principal Investigator, Cytokines as predictors of disease progression in scleroderma lung disease. 9/1/06-8/31/10. $880,000 direct costs (Tansferrred to another PI upon my leaving UCLA)

NIH P50 HL67655 Principal investigator, Project 2 (35% effort), TH2 cytokines and CC chemokines in Pulmonary Fibrosis, 9/1/01-8/31/06 ($904,902 direct costs).

Sunol Molecular Corporation, Principal Investigator, The safety, Pharmacokinetics and Physiological Effects of Sunol-cH36 in patients with acute lung injury/acute respiratory distress syndrome. 2/1/2005-1/31/2007.

NIH KO8 HL03906, Principal Investigator (80% effort), "Chemokines regulate angiogenesis in pulmonary fibrosis"; 2/1/99-1/31/2004 ($620,000 direct costs)

Council on Research of the Academic Senate at UCLA, Assistant Professor Initiative, "CC chemokines and TH2 cytokines in Pulmonary Fibrosis", 11/1/00-6/30/01 ($2,000)

American Lung Association Dalsemer Research Scholar Award, "TH2 cytokines and CC chemokines in Pulmonary Fibrosis", 7/1/01-6/30/03 ($49, 970).

Research Projects: